FLUORINE-CONTAINING INTEGRIN ANTAGONISTS Russian patent published in 2019 - IPC C07D471/04 A61K31/4375 A61K31/444 A61K31/506 A61P27/02 

Abstract RU 2698195 C2

FIELD: chemistry.

SUBSTANCE: invention relates to organic chemistry and specifically to a heterocyclic compound of formula I or a pharmaceutically acceptable salt thereof, where Z is or ; R and R' denote H; Q is or ; X is CH or N; Y is CH or N; R1 is C1-C4 alkyl substituted with 1, 2, 3, 4, 5, 6, 7, 8 or 9 fluorine atoms, or C1-C6 an alkoxy group substituted with 1, 2, 3, 4, 5, 6 or 7 fluorine atoms; and R2 and R3 independently of each other are H, F, CH2F, CHF2 or CF3, provided that one of R2 and R3 is not H, provided that compound of formula I contains at least one fluorine atom. Invention also relates to a pharmaceutical composition based on a compound of formula I and use of the compound of formula I.

EFFECT: technical result is obtaining novel heterocyclic compounds effective for treating or preventing a disease mediated by αv integrin.

37 cl, 5 dwg, 9 tbl, 18 ex

Similar patents RU2698195C2

Title Year Author Number
NAPHTHYRIDIN DERIVATIVES AS ANTAGONISTS OF ALPHA V BETA 6 INTEGRIN FOR TREATING, IN PARTICULAR, FIBROTIC DISEASES 2015
  • Anderson, Niall Andrew
  • Campbell, Ian Baxter
  • Campbell-Crawford, Matthew Howard James
  • Hancock, Ashley Paul
  • Lemma, Seble
  • Macdonald, Simon John Fawcett
  • Pritchard, John Martin
  • Procopiou, Panayiotis Alexandrou
RU2692775C2
PIPERIDINYL COMPOUNDS FOR SELECTIVE INTEGRINE BINDING 2003
  • De Kort Bart
  • Kinni Uill'Jam A.
  • Marianoff Brjus Eh.
  • Gkhosh Sh'Jamali
  • Lju Li
RU2333210C2
AVB6 INTEGRIN INHIBITORS 2018
  • Brewer, Mark
  • Bursavich, Matthew, Gregory
  • Gerasyuto, Aleksey Igorevich
  • Hahn, Kristopher, Neil
  • Harrison, Bryce, Alden
  • Konze, Kyle, David
  • Lin, Fu-Yang
  • Lippa, Blaise, Scott
  • Lugovskoy, Alexey Alexandrovich
  • Rogers, Bruce, Nelsen
  • Svensson, Mats, Ake
  • Troast, Dawn, Marie
RU2769702C2
TRKA KINASE INHIBITORS, COMPOSITIONS BASED THEREON AND METHODS 2015
  • Mitchell Khelen
  • Freli Mark E.
  • Kuk Endryu Dzh.
  • Chen I-Khen
  • Stamp Krejg A.
  • Chzhan Syuj-Fan
  • Makkomas Kejsi S.
  • Shirripa Keti
  • Makverter Melodi
  • Merser Svati P.
  • Babaoglu Kerim
  • Men Dunfan
  • Vu Dzhejn
  • Lyu Pin
  • Vud Kharold B.
  • Bao Tszyanmin
  • Li Chun Sing
  • Mao Tsinkhua
  • Tsi Chzhitsi
RU2672583C2
3-CARBOXYPROPYL-AMINOTETRALINE DERIVATIVES AND RELATED COMPOUNDS AS MU-OPIOID RECEPTOR ANTAGONISTS 2008
  • Trehpp Shon Dzh.
  • Lidbetter Majkl R.
  • Long Dehniel D.
  • Dzhekobsen Dzhon R.
  • Van Dajk Pristsilla
  • Kol'Son P'Er-Zhan
  • Rapta Miroslav
  • Juj In
RU2482107C2
COMPOUNDS EXHIBITING SELECTIVITY WITH RESPECT TO RETINOID RECEPTORS, PHARMACEUTICAL COMPOSITION (VARIANTS), METHOD OF MODULATION OF PROCESSES (VARIANTS), METHOD OF SUPPRESSION OF PATHOLOGICAL STATES 1993
  • Markus F.Boehm
  • Richard A.Khejman
  • Lin Tskhi
RU2144913C1
NEW PYRIDINE DERIVATIVES, METHOD FOR MAKING THEREOF AND RELATED PHARMACEUTICAL COMPOSITION 2004
  • Kim Khiung-Ook
  • Li Nam Kiu
  • Kim Dzoo Khion
  • Rkhee Khae In
  • Cho Jong-Baik
  • Riu Dze Kho
  • Kim Nam Kho
  • Riu Keun Kho
  • Ji Dzung Bum
  • Dzung Dzae Joon
RU2366659C2
NITROIMIDAZOLE DERIVATIVE AGAINST PULMONARY TUBERCULOSIS 2016
  • Luo, Wei
  • Ding, Charles Z.
  • Huang, Zhigang
  • Chen, Shuhui
RU2675622C1
SERIN / TREONIN KINASE INHIBITORS FOR TREATING OF HYPEROPLIFERATIVE DISEASES 2013
  • Blejk Dzhim
  • Chen Khojfen
  • Chikarelli Mark
  • Gaudino Dzhon
  • Gazzard Lyuis
  • Kintz Sem
  • Mor Pit
  • Robardzh Kirk
  • Shvarts Dzhejkob
  • Chzhou Ajkhe
RU2644947C2
THIOPHENYL AND PYRROLYL AZEPINES AS SEROTONIN 5HT RECEPTOR LIGANDS AND USE THEREOF 2007
  • T'Jumi L. Natan
  • Bom Dehvid K.
  • Bennani Jussef L.
  • Robardzh Majkl Dzh.
RU2434872C2

RU 2 698 195 C2

Authors

Askyu Ben S.

Khajdebrekht Richard V.

Furuya Takeru

Daggen Mark E.

Edvards D. Skott

Dates

2019-08-23Published

2014-02-07Filed